newsfilter
← Latest News
GlobeNewswire·

Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements

Delivered quarterly XDEMVY® net sales of approximately $119 million, up approximately 147% year-over-year Weekly multi-patient prescribers grew approximately 30% in the third quarter underscoring strong commercial